NCT01792193View on ClinicalTrials.gov

Gut-derived Neuropeptides in Cerebrospinal Fluid of Patients With Parkinson's Disease and Healthy Controls

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Parkinson's Disease
Trial Locations (1)

66421

Saarland University, Homburg / Saar

All Listed Sponsors
lead

Dr. Marcus Unger

OTHER

NCT01792193 - Gut-derived Neuropeptides in Cerebrospinal Fluid of Patients With Parkinson's Disease and Healthy Controls | Biotech Hunter | Biotech Hunter